Evidence map›Paper›PMID 26307515›Full record

ArticleScientific reports2015

Protein retention on plasma-treated hierarchical nanoscale gold-silver platform.

Jinghua Fang, Igor Levchenko, Anne Mai-Prochnow, Michael Keidar, Uros Cvelbar, Gregor Filipic, Zhao Jun Han, Kostya Ken Ostrikov

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Carbon nanotubes as anti-bacterial agents.Cellular and molecular life sciences : CMLS · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jinghua FangPlasma Nanoscience Laboratories, Manufacturing Flagship, Commonwealth Scientific and Industrial Research Organisation (CSIRO), P.O. Box 218, Lindfield, NSW 2070, Australia.
Igor LevchenkoPlasma Nanoscience Laboratories, Manufacturing Flagship, Commonwealth Scientific and Industrial Research Organisation (CSIRO), P.O. Box 218, Lindfield, NSW 2070, Australia.
Anne Mai-ProchnowPlasma Nanoscience Laboratories, Manufacturing Flagship, Commonwealth Scientific and Industrial Research Organisation (CSIRO), P.O. Box 218, Lindfield, NSW 2070, Australia.
Michael KeidarDepartment of Mechanical and Aerospace Engineering, The George Washington University, Washington, DC 20052, USA.
Uros CvelbarJozef Stefan Institute, Dep. of Surface Eng. and Optoelectronics, Jamova 39, 1000 Ljubljana, Slovenia, EU.
Gregor FilipicJozef Stefan Institute, Dep. of Surface Eng. and Optoelectronics, Jamova 39, 1000 Ljubljana, Slovenia, EU.
Zhao Jun HanPlasma Nanoscience Laboratories, Manufacturing Flagship, Commonwealth Scientific and Industrial Research Organisation (CSIRO), P.O. Box 218, Lindfield, NSW 2070, Australia.
Kostya Ken OstrikovPlasma Nanoscience Laboratories, Manufacturing Flagship, Commonwealth Scientific and Industrial Research Organisation (CSIRO), P.O. Box 218, Lindfield, NSW 2070, Australia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dense arrays of gold-supported silver nanowires of about 100 nm in diameter grown directly in the channels of nanoporous aluminium oxide membrane were fabricated and tested as a novel platform for the immobilization and retention of BSA proteins in the microbial-protective environments. Additional treatment of the silver nanowires using low-temperature plasmas in the inductively-coupled plasma reactor and an atmospheric-pressure plasma jet have demonstrated that the morphology of the nanowire array can be controlled and the amount of the retained protein may be increased due to the plasma effect. A combination of the neutral gold sublayer with the antimicrobial properties of silver nanowires could significantly enhance the efficiency of the platforms used in various biotechnological processes.

Indexed as

AdsorptionGoldMaterials TestingMetal NanoparticlesParticle SizePlasma GasesProtein BindingSerum Albumin, BovineSilverSurface PropertiesGoldPlasma GasesSerum Albumin, BovineSilver

Identifiers

PMID26307515
PMCPMC4549625

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.